Cosmos Health stock, reverse stock split

Cosmos Health stock gets 1-for-20 reverse split on Nov. 13

Published on 11/13/2026 at 22:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Cosmos Health stock moved to a 1-for-20 reverse split on Friday. Authorized share limits stayed unchanged.

Reverse split reshapes share count

  • Cosmos Health implemented a 1-for-20 reverse stock split on Friday, November 13, 2026.
  • The company kept its authorized common and preferred share limits unchanged.
  • The amendment followed a corrected SEC filing that separated the charter date from the split effective date.
Cosmos Health stock, reverse stock split, Nasdaq, healthcare, COSM, Illustration mit AI erstellt.

Cosmos Health implemented a 1-for-20 reverse stock split on Friday, November 13, 2026, after the company corrected the effective dates in an amended Form 8-K filed with the U.S. Securities and Exchange Commission on November 10. The filing states that each 20 common shares were consolidated into one share.

Share structure stays unchanged

The company maintained authorization for 1,500,000,000 common shares and 300,000,000 preferred shares. The board approved the split ratio on October 27, while the certificate of amendment was filed with Nevada on November 9.

The certificate became effective at 4 p.m. local time on November 12, according to the amended SEC filing. The reverse split itself followed on November 13.

A reverse split reduces the number of shares outstanding while adjusting the per-share price mechanically. It does not by itself change the companys aggregate equity value, although the unchanged authorized share ceiling leaves room for future issuance.

Cosmos Health at a glance

  • Company: Cosmos Health Inc.
  • Ticker: COSM
  • Exchange: Nasdaq Capital Market
  • Corporate action: 1-for-20 reverse stock split
  • Effective date: November 13, 2026
  • Authorized common shares: 1,500,000,000
  • Authorized preferred shares: 300,000,000

The broader Nasdaq Composite market provides the relevant U.S. equity backdrop for the Nasdaq-listed company.

Current market reports provide wider trading context.

Disclaimer...
en | boerse | 70506850 |